These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17997799)

  • 41. Tamoxifen-induced ultraviolet, recall dermatitis.
    Ledet JJ; Grafton LH
    J Drugs Dermatol; 2009 Aug; 8(8):761-2. PubMed ID: 19663115
    [No Abstract]   [Full Text] [Related]  

  • 42. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
    Litsas G
    Oncol Nurs Forum; 2008 Jul; 35(4):714-21. PubMed ID: 18591176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Registries contribute to better breast cancer care].
    Bergkvist L; Liljegren G; Ahlgren J; Lidin A; Holmqvist M; Holmberg L
    Lakartidningen; 2004 Aug; 101(34):2579-81. PubMed ID: 15446697
    [No Abstract]   [Full Text] [Related]  

  • 45. Androgens and androgen receptors: a clinically neglected sector in breast cancer biology.
    Moe RE; Anderson BO
    J Surg Oncol; 2007 May; 95(6):437-9. PubMed ID: 17192921
    [No Abstract]   [Full Text] [Related]  

  • 46. Proceedings of the First International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: summary consensus statement.
    Buzdar AU; Come SE; Brodie A; Ellis M; Goss PE; Ingle JN; Johnston SR; Lee AV; Osborne CK; Vogel VG; Hart CS
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4335s-4337s; discussion 4411s-4412s. PubMed ID: 11916221
    [No Abstract]   [Full Text] [Related]  

  • 47. Hot flashes may be a good sign in women taking tamoxifen.
    Mayo Clin Womens Healthsource; 2007 Nov; 11(11):3. PubMed ID: 17898683
    [No Abstract]   [Full Text] [Related]  

  • 48. Making use of modeling and simulations: Towards individualized tamoxifen therapy in breast cancer
.
    Klopp-Schulze L; Joerger M; Wicha SG; Parra-Guillen ZP; Kloft C
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):690-691. PubMed ID: 27641215
    [No Abstract]   [Full Text] [Related]  

  • 49. Adjuvant endocrine therapy with tamoxifen: side-effects on the female genital tract are not always what they seem.
    Mourits MJ; Buijs C
    Ann Oncol; 2012 Nov; 23(11):2990. PubMed ID: 23091232
    [No Abstract]   [Full Text] [Related]  

  • 50. Psoriasis and tamoxifen therapy: a case report.
    Ferrari VD; Jirillo A
    Tumori; 1996; 82(3):262-3. PubMed ID: 8693608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tamoxifen reduces breast cancer by a third in high risk women.
    Mayor S
    BMJ; 2002 Sep; 325(7365):613. PubMed ID: 12242163
    [No Abstract]   [Full Text] [Related]  

  • 52. The limits of tamoxifen.
    Kennedy MJ
    Ir J Med Sci; 2002; 171(1):8-9. PubMed ID: 11993605
    [No Abstract]   [Full Text] [Related]  

  • 53. Tamoxifen in breast cancer survivors with COVID 19: stop or go?
    Karacin C; Karacin P; Ergun Y
    Med Oncol; 2021 Mar; 38(4):42. PubMed ID: 33730224
    [No Abstract]   [Full Text] [Related]  

  • 54. A better option?
    Gorman C
    Time; 2006 May; 167(18):70. PubMed ID: 16689077
    [No Abstract]   [Full Text] [Related]  

  • 55. Primary endocrine treatment for breast cancer in the elderly.
    Kontos M; Kostakis ID; Constantinidou A; Parkin A; Fletcher M; Coltman L; Beard S; Kumar I
    Breast J; 2020 Mar; 26(3):585-587. PubMed ID: 31495036
    [No Abstract]   [Full Text] [Related]  

  • 56. Words, words, words.
    Ruse WH
    Med J Aust; 2007 Aug; 187(4):255-6; author reply 256. PubMed ID: 17708737
    [No Abstract]   [Full Text] [Related]  

  • 57. Endocrine Treatment for 5 Years or Radiation for 5 Days for Patients With Early Breast Cancer Older Than 65 Years: Can We Do It Right?
    Naoum GE; Taghian AG
    J Clin Oncol; 2023 May; 41(13):2331-2336. PubMed ID: 36538740
    [No Abstract]   [Full Text] [Related]  

  • 58. Proven value of translational research with appropriate animal models to advance breast cancer treatment and save lives: the tamoxifen tale.
    Jordan VC
    Br J Clin Pharmacol; 2015 Feb; 79(2):254-67. PubMed ID: 24912921
    [No Abstract]   [Full Text] [Related]  

  • 59. Interpreting quality-of-life data from the SOFT and TEXT trials.
    Chlebowski RT
    Lancet Oncol; 2015 Jul; 16(7):749-51. PubMed ID: 26092819
    [No Abstract]   [Full Text] [Related]  

  • 60. Tamoxifen therapy for aggressive fibromatosis of the posterior triangle of the neck.
    Morris LG; Sikora AG; Kuriakose MA; DeLacure MD
    Otolaryngol Head Neck Surg; 2007 Apr; 136(4):674-6. PubMed ID: 17418276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.